Annalisa Pacilli

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.

Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis.

Journal: Blood advances

Published: October 21, 2020

Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.

Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera.

Journal: American journal of hematology

Published: June 10, 2020

Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.

Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature.

Journal: Clinical and experimental medicine

Published: November 05, 2019

Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.

Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms.

Journal: American journal of hematology

Published: October 16, 2019

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera.

Journal: British journal of haematology

Published: August 21, 2019

Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.

Spectrum of ASXL1 mutations in primary myelofibrosis: prognostic impact of the ASXL1 p.G646Wfs*12 mutation.

Journal: Blood

Published: May 12, 2019

Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.

Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis.

Journal: American journal of hematology

Published: March 23, 2019

A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.

A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.

Journal: Hematological oncology

Published: October 14, 2018

Validation of the Mayo alliance prognostic system for mastocytosis.

Validation of the Mayo alliance prognostic system for mastocytosis.

Journal: Blood cancer journal

Published: October 13, 2018

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea.

Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea.

Journal: Blood cancer journal

Published: September 11, 2018

Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.

Bone marrow-specific loss of ABI1 induces myeloproliferative neoplasm with features resembling human myelofibrosis.

Journal: Blood

Published: May 02, 2018

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 12, 2017

Showing 1-12 of 34

Last Updated: 09/26/2026